The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage

Blood

Volumn 130, Issue 10, 2017, Pages 1223-1234

  Del Prete, Annalisa ^a,b   Martínez Muñoz, Laura ^c   Mazzon, Cristina ^b   Toffali, Lara ^d   Sozio, Francesca ^a,b   Za, Lorena ^e   Bosisio, Daniela ^a   Gazzurelli, Luisa ^a   Salvi, Valentina ^a   Tiberio, Laura ^a   Liberati, Chiara ^e   Scanziani, Eugenio ^f   Vecchi, Annunciata ^b   Laudanna, Carlo ^d   Mellado, Mario ^c   Mantovani, Alberto ^b,g,h   Sozzani, Silvano ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d UNIVERSITY OF VERONA   (Italy)

^e Axxam Discovery Biology   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g HUMANITAS UNIVERSITY   (Italy)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; CHEMOKINE RECEPTOR CCR; CHEMOKINE RECEPTOR CCRL 2; CHEMOKINE RECEPTOR CXCR2; CHEMOTACTIC PEPTIDE; HETERODIMER; HOMODIMER; UNCLASSIFIED DRUG; CCRL2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIMERIZATION; IN VITRO STUDY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ANIMAL; ARTHRITIS; CELL SURVIVAL; CHEMISTRY; COMPLICATION; DEFICIENCY; DISEASE MODEL; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION;

ANIMALS; ANTIGENS, CD18; ARTHRITIS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; INFLAMMATION; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-8B; SIGNAL TRANSDUCTION;

EID: 85029310524     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2017-04-777680     Document Type: Article

References (55)

1. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol. 2006;6(12):907-918.
2. Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(10):593-601.
3. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678-689.
4. Alon R, Ley K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol. 2008;20(5):525-532.
5. Montresor A, Toffali L, Constantin G, Laudanna C. Chemokines and the signaling modules regulating integrin affinity. Front Immunol. 2012;3:127.
6. Bachelerie F, Ben-Baruch A, Burkhardt AM, et al. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev. 2013;66(1):1-79.
7. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 2001;22(6):328-336.
8. Bonecchi R, Graham GJ. Atypical chemokine receptors and their roles in the resolution of the inflammatory response. Front Immunol. 2016;7:224.
9. Nibbs RJ, Graham GJ. Immune regulation by atypical chemokine receptors. Nat Rev Immunol. 2013;13(11):815-829.
10. Del Prete A, Bonecchi R, Vecchi A, Mantovani A, Sozzani S. CCRL2, a fringe member of the atypical chemoattractant receptor family. Eur J Immunol. 2013;43(6):1418-1422.
11. De Henau O, Degroot GN, Imbault V, et al. Signaling properties of chemerin receptors CMKLR1, GPR1 and CCRL2. PLoS One. 2016;11(10):e0164179.
12. Zabel BA, Nakae S, Zúñiga L, et al. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med. 2008;205(10):2207-2220.
13. Gonzalvo-Feo S, Del Prete A, Pruenster M, et al. Endothelial cell-derived chemerin promotes dendritic cell transmigration. J Immunol. 2014;192(5):2366-2373.
14. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159-175.
15. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11(8):519-531.
16. Otero K, Vecchi A, Hirsch E, et al. Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood. 2010;116(16):2942-2949.
17. Del Prete A, Vermi W, Dander E, et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J. 2004;23(17):3505-3515.
18. Hasenberg M, Köhler A, Bonifatius S, et al. Rapid immunomagnetic negative enrichment of neutrophil granulocytes from murine bone marrow for functional studies in vitro and in vivo. PLoS One. 2011;6(2):e17314.
19. Hirsch E, Katanaev VL, Garlanda C, et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science. 2000;287(5455):1049-1053.
20. Bozic CR, Gerard NP, von Uexkull-Guldenband C, et al. The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem. 1994;269(47):29355-29358.
21. Shao WH, Del Prete A, Bock CB, Haribabu B. Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice. J Immunol. 2006;176(10):6254-6261.
22. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell. 1996;87(5):811-822.
23. Coelho FM, Pinho V, Amaral FA, et al. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature. Arthritis Rheum. 2008;58(8):2329-2337.
24. Bolomini-Vittori M, Montresor A, Giagulli C, et al. Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat Immunol. 2009;10(2):185-194.
25. Martínez Muñoz L, Lucas P, Navarro G, et al. Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers. J Immunol. 2009;183(11):7337-7346.
26. Zimmermann T, Rietdorf J, Girod A, Georget V, Pepperkok R. Spectral imaging and linear unmixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair. FEBS Lett. 2002;531(2):245-249.
27. Tanaka D, Kagari T, Doi H, Shimozato T. Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology. 2006;119(2):195-202.
28. Chou RC, Kim ND, Sadik CD, et al. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity. 2010;33(2):266-278.
29. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2(5):1269-1275.
30. Campbell IK, Hamilton JA, Wicks IP. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol. 2000;30(6):1568-1575.
31. Monach PA, Mathis D, Benoist C. The K/BxN arthritis model. Curr Protoc Immunol. 2008; Chapter 15:Unit 15.22.
32. Christensen AD, Haase C, Cook AD, Hamilton JA. K/BxN serum-transfer arthritis as a model for human inflammatory arthritis. Front Immunol. 2016;7:213.
33. Monnier J, Lewén S, O’Hara E, et al. Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells. J Immunol. 2012;189(2):956-967.
34. Bonecchi R, Facchetti F, Dusi S, et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol. 2000;164(7):3862-3869.
35. Bondue B, Wittamer V, Parmentier M. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev. 2011;22(5-6):331-338.
36. Jannat RA, Robbins GP, Ricart BG, Dembo M, Hammer DA. Neutrophil adhesion and chemotaxis depend on substrate mechanics. J Phys Condens Matter. 2010;22(19):194117.
37. Mellado M, Rodríguez-Frade JM, Vila-Coro AJ, et al. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J. 2001;20(10):2497-2507.
38. Sierro F, Biben C, Martínez-Muñoz L, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA. 2007;104(37):14759-14764.
39. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood. 2009;113(24):6085-6093.
40. Barroso R, Martínez Muñoz L, Barrondo S, et al. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5. FASEB J. 2012; 26(12):4841-4854.
41. Nauseef WM, Borregaard N. Neutrophils at work. Nat Immunol. 2014;15(7):602-611.
42. Eyles JL, Hickey MJ, Norman MU, et al. A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood. 2008;112(13):5193-5201.
43. Galligan CL, Matsuyama W, Matsukawa A, et al. Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. Arthritis Rheum. 2004;50(6):1806-1814.
44. Tecchio C, Cassatella MA. Neutrophil-derived chemokines on the road to immunity. Semin Immunol. 2016;28(2):119-128.
45. Zschaler J, Schlorke D, Arnhold J. Differences in innate immune response between man and mouse. Crit Rev Immunol. 2014;34(5):433-454.
46. Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol. 2016;12(8):472-485.
47. Gottenberg JE, Brocq O, Perdriger A, et al. Non-TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial. JAMA. 2016;316(11): 1172-1180.
48. Monach PA, Nigrovic PA, Chen M, et al. Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1. Arthritis Rheum. 2010;62(3):753-764.
49. Thelen M, Muñoz LM, Rodríguez-Frade JM, Mellado M. Chemokine receptor oligomerization: functional considerations. Curr Opin Pharmacol. 2010;10(1):38-43.
50. Chakera A, Seeber RM, John AE, Eidne KA, Greaves DR. The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization. Mol Pharmacol. 2008;73(5):1362-1370.
51. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol. 2004;22:891-928.
52. Bonecchi R, Savino B, Borroni EM, Mantovani A, Locati M. Chemokine decoy receptors: structure-function and biological properties. Curr Top Microbiol Immunol. 2010;341:15-36.
53. Colditz IG, Schneider MA, Pruenster M, Rot A. Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance. Thromb Haemost. 2007;97(5):688-693.
54. Borroni EM, Cancellieri C, Vacchini A, et al. β-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6. Sci Signal. 2013;6(273):ra30.1-11, S1-3. doi: 10.1126/scisignal.2003627
55. Jakubzick C, Tacke F, Llodra J, van Rooijen N, Randolph GJ. Modulation of dendritic cell trafficking to and from the airways. J Immunol. 2006;176(6):3578-3584.